Ruina Gao
About Ruina Gao
Ruina Gao is the Associate Director of Clinical Pharmacology and Pharmacometrics at Bristol Myers Squibb in Shanghai, China, with over a decade of experience in Preclinical DMPK and Clinical Pharmacology.
Title
Ruina Gao currently holds the position of Associate Director, Clinical Pharmacology and Pharmacometrics, at Bristol Myers Squibb in Shanghai, China. She has been serving in this role since December 2021. In this capacity, she leverages her extensive background and expertise in clinical pharmacology to contribute to the company’s research and development efforts.
Company
Bristol Myers Squibb, where Ruina Gao works, is a global biopharmaceutical company committed to discovering, developing, and delivering innovative medicines. The company's mission focuses on helping patients prevail over serious diseases through its extensive research and development initiatives. In her role, Ruina Gao is part of the Clinical Pharmacology and Pharmacometrics team, contributing to the development of new therapies in Shanghai, China.
Previous Experience at Novartis
Prior to her current role, Ruina Gao worked at Novartis as a Clinical Pharmacologist - Investigator III. She was employed there from 2018 to 2021, spending three years in Shanghai, China. At Novartis, she was involved in clinical pharmacology projects, applying her expertise in drug metabolism and pharmacokinetics (DMPK) to support drug development.
Previous Experience at WuXi AppTec
Before joining Novartis, Ruina Gao worked for nine months at WuXi AppTec as a Clinical Pharmacologist. Her role involved supporting various clinical pharmacology studies and applying her skills in DMPK to aid in the development and optimization of pharmaceutical products.
Educational Background
Ruina Gao holds a Ph.D. in Pharmaceutical Analysis with a focus on DMPK from the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, where she studied from 2007 to 2012. She also earned a Bachelor's degree in Pharmacy from China Pharmaceutical University, where she studied from 2003 to 2007. Her academic background has provided her with a strong foundation in pharmaceutical sciences and analytical techniques.
Expertise in Pharmaceutical Analysis and DMPK
With over a decade of experience, Ruina Gao has specialized knowledge in both preclinical DMPK and clinical pharmacology. Her comprehensive expertise includes working on drug metabolism, pharmacokinetics studies, and pharmaceutical analysis, which she has applied throughout her career at companies like GSK, WuXi AppTec, Novartis, and currently Bristol Myers Squibb.